Immediate Impact

5 from Science/Nature 77 standout
Sub-graph 1 of 23

Citing Papers

Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
2024 Standout
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
3 intermediate papers

Works of S. Edwards being referenced

Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance
2007
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population
2005

Author Peers

Author Last Decade Papers Cites
S. Edwards 196 113 55 125 8 373
A Ionescu 218 36 53 99 14 336
J-P Collet 114 23 50 32 7 359
Linda Carlsson 62 131 83 96 9 346
Mitch Goldman 262 63 43 240 7 413
Ariane Duval-Sabatier 57 122 25 65 10 438
Jerry Buysse 178 135 22 60 8 450
John Tuckey 64 132 67 98 11 434
Alessandro Budakovic 94 47 39 39 9 345
Janusz Ławiński 58 170 51 94 15 439
Mina Yu 53 129 34 64 12 454

All Works

Loading papers...

Rankless by CCL
2026